Historical record - last NADAC publication: 8/23/2023
Product Information
ATORVASTATIN 40 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.0565 per EA under NDC 69097094615. Its NADAC has been published 294 times since Jan 10, 2018.
The High Outlier badge above means this manufacturer's average price in the ATORVASTATIN CALCIUM market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
40 mg/1
Manufacturer
Cipla USA Inc.NDC
69097094615
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
8/23/2023
Active Ingredients
ATORVASTATIN CALCIUM TRIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA205519On Market Since
11/16/2017
Pharmacological Classes
Price Statistics
The NADAC for ATORVASTATIN 40 MG TABLET has been published 294 times since Jan 10, 2018, and over the history we have for it it has declined 41.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0565 per EA |
|---|---|
| All-time high | $0.1257 (Sep 12, 2018) |
| All-time low | $0.0557 (Jul 20, 2022) |
| Median price | $0.0770 |
| Average price | $0.0809 |
| Largest weekly change | +17.3% (Jul 22, 2020) |
| Weeks tracked | 294 |
| Tracking since | Jan 10, 2018 |
Generic Alternatives
The matcher finds 10 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 33% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ATORVASTATIN 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ATORVASTATIN 40 MG TABLET, manufactured by Cipla USA Inc., is $0.0565 per EA (NDC 69097094615), effective Aug 23, 2023.
How has the price of ATORVASTATIN 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for ATORVASTATIN 40 MG TABLET has declined 41.4%. It has been tracked across 294 weekly CMS publications since Jan 10, 2018.
What are the highest and lowest recorded NADAC prices for ATORVASTATIN 40 MG TABLET?
Since Jan 10, 2018, the NADAC for ATORVASTATIN 40 MG TABLET has ranged from a low of $0.0557 (Jul 20, 2022) to a high of $0.1257 (Sep 12, 2018), with a median of $0.0770 per EA.
Are there cheaper alternatives to ATORVASTATIN 40 MG TABLET?
Yes. 10 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, ATORVASTATIN 40 MG TABLET, is $0.0379 per EA — about 33% below ATORVASTATIN 40 MG TABLET.
Who manufactures ATORVASTATIN 40 MG TABLET?
ATORVASTATIN 40 MG TABLET (NDC 69097094615) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification